KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 18 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $10,456,000 | -59.1% | 10,000,000 | -60.0% | 0.04% | -66.1% |
| Q1 2021 | $25,538,000 | -41.3% | 25,000,000 | -28.6% | 0.13% | -51.5% |
| Q4 2020 | $43,527,000 | -6.8% | 35,000,000 | -9.1% | 0.26% | -18.9% |
| Q3 2020 | $46,694,000 | -7.1% | 38,523,000 | +9.7% | 0.32% | -19.7% |
| Q2 2020 | $50,287,000 | +1.7% | 35,102,000 | 0.0% | 0.40% | -5.4% |
| Q1 2020 | $49,460,000 | +43.7% | 35,102,000 | +46.3% | 0.42% | +83.2% |
| Q4 2019 | $34,430,000 | – | 24,000,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 20,000,000 | $25,176,000 | 1.70% |
| DeepCurrents Investment Group LLC | 22,530,000 | $28,226,000 | 0.74% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | $24,888,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 35,000,000 | $43,527,000 | 0.26% |
| AQR Arbitrage LLC | 4,100,000 | $5,164,000 | 0.18% |
| CSS LLC/IL | 3,000,000 | $3,781,000 | 0.14% |
| Verition Fund Management LLC | 6,579,000 | $8,286,000 | 0.07% |
| LAZARD ASSET MANAGEMENT LLC | 16,500,000 | $20,780,000 | 0.03% |
| Citadel Advisors | 43,300,000 | $54,252,000 | 0.01% |
| CREDIT SUISSE AG/ | 5,017,000 | $6,243,000 | 0.00% |